Global SPECT and PET Radiopharmaceuticals Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 04 Jul 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global SPECT and PET Radiopharmaceuticals market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global SPECT and PET Radiopharmaceuticals demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for SPECT and PET Radiopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of SPECT and PET Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global SPECT and PET Radiopharmaceuticals total market, 2018-2029, (USD Million)
Global SPECT and PET Radiopharmaceuticals total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: SPECT and PET Radiopharmaceuticals total market, key domestic companies and share, (USD Million)
Global SPECT and PET Radiopharmaceuticals revenue by player and market share 2018-2023, (USD Million)
Global SPECT and PET Radiopharmaceuticals total market by Type, CAGR, 2018-2029, (USD Million)
Global SPECT and PET Radiopharmaceuticals total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global SPECT and PET Radiopharmaceuticals market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Cardinal Health, Curium Pharma, China Isotope & Radiation, Jubilant Life Sciences, Bracco, Yantai Dongcheng Pharmaceutical, Lantheus Medical Imaging, Inc. and Eczacıbaşı Monrol Nuclear Products, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World SPECT and PET Radiopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global SPECT and PET Radiopharmaceuticals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global SPECT and PET Radiopharmaceuticals Market, Segmentation by Type
Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Positron Emission Tomography (PET) Radiopharmaceuticals

Global SPECT and PET Radiopharmaceuticals Market, Segmentation by Application
Hospitals
Clinics
Others

Companies Profiled:
GE Healthcare
Cardinal Health
Curium Pharma
China Isotope & Radiation
Jubilant Life Sciences
Bracco
Yantai Dongcheng Pharmaceutical
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens

Key Questions Answered
1. How big is the global SPECT and PET Radiopharmaceuticals market?
2. What is the demand of the global SPECT and PET Radiopharmaceuticals market?
3. What is the year over year growth of the global SPECT and PET Radiopharmaceuticals market?
4. What is the total value of the global SPECT and PET Radiopharmaceuticals market?
5. Who are the major players in the global SPECT and PET Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 SPECT and PET Radiopharmaceuticals Introduction
    1.2 World SPECT and PET Radiopharmaceuticals Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World SPECT and PET Radiopharmaceuticals Total Market by Region (by Headquarter Location)
        1.3.1 World SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.3 China SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.4 Europe SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.5 Japan SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.6 South Korea SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.7 ASEAN SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
        1.3.8 India SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 SPECT and PET Radiopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 SPECT and PET Radiopharmaceuticals Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.2 World SPECT and PET Radiopharmaceuticals Consumption Value by Region
        2.2.1 World SPECT and PET Radiopharmaceuticals Consumption Value by Region (2018-2023)
        2.2.2 World SPECT and PET Radiopharmaceuticals Consumption Value Forecast by Region (2024-2029)
    2.3 United States SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.4 China SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.5 Europe SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.6 Japan SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.7 South Korea SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.8 ASEAN SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)
    2.9 India SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029)

3 World SPECT and PET Radiopharmaceuticals Companies Competitive Analysis
    3.1 World SPECT and PET Radiopharmaceuticals Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global SPECT and PET Radiopharmaceuticals Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for SPECT and PET Radiopharmaceuticals in 2022
        3.2.3 Global Concentration Ratios (CR8) for SPECT and PET Radiopharmaceuticals in 2022
    3.3 SPECT and PET Radiopharmaceuticals Company Evaluation Quadrant
    3.4 SPECT and PET Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.4.1 SPECT and PET Radiopharmaceuticals Market: Region Footprint
        3.4.2 SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
        3.4.3 SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: SPECT and PET Radiopharmaceuticals Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: SPECT and PET Radiopharmaceuticals Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: SPECT and PET Radiopharmaceuticals Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: SPECT and PET Radiopharmaceuticals Consumption Value Comparison
        4.2.1 United States VS China: SPECT and PET Radiopharmaceuticals Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: SPECT and PET Radiopharmaceuticals Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based SPECT and PET Radiopharmaceuticals Companies and Market Share, 2018-2023
        4.3.1 United States Based SPECT and PET Radiopharmaceuticals Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023)
    4.4 China Based Companies SPECT and PET Radiopharmaceuticals Revenue and Market Share, 2018-2023
        4.4.1 China Based SPECT and PET Radiopharmaceuticals Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023)
    4.5 Rest of World Based SPECT and PET Radiopharmaceuticals Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based SPECT and PET Radiopharmaceuticals Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World SPECT and PET Radiopharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
        5.2.2 Positron Emission Tomography (PET) Radiopharmaceuticals
    5.3 Market Segment by Type
        5.3.1 World SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
        5.3.2 World SPECT and PET Radiopharmaceuticals Market Size by Type (2024-2029)
        5.3.3 World SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World SPECT and PET Radiopharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
        6.3.2 World SPECT and PET Radiopharmaceuticals Market Size by Application (2024-2029)
        6.3.3 World SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2029)

7 Company Profiles
    7.1 GE Healthcare
        7.1.1 GE Healthcare Details
        7.1.2 GE Healthcare Major Business
        7.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Product and Services
        7.1.4 GE Healthcare SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 GE Healthcare Recent Developments/Updates
        7.1.6 GE Healthcare Competitive Strengths & Weaknesses
    7.2 Cardinal Health
        7.2.1 Cardinal Health Details
        7.2.2 Cardinal Health Major Business
        7.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Product and Services
        7.2.4 Cardinal Health SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Cardinal Health Recent Developments/Updates
        7.2.6 Cardinal Health Competitive Strengths & Weaknesses
    7.3 Curium Pharma
        7.3.1 Curium Pharma Details
        7.3.2 Curium Pharma Major Business
        7.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Product and Services
        7.3.4 Curium Pharma SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Curium Pharma Recent Developments/Updates
        7.3.6 Curium Pharma Competitive Strengths & Weaknesses
    7.4 China Isotope & Radiation
        7.4.1 China Isotope & Radiation Details
        7.4.2 China Isotope & Radiation Major Business
        7.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Services
        7.4.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 China Isotope & Radiation Recent Developments/Updates
        7.4.6 China Isotope & Radiation Competitive Strengths & Weaknesses
    7.5 Jubilant Life Sciences
        7.5.1 Jubilant Life Sciences Details
        7.5.2 Jubilant Life Sciences Major Business
        7.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product and Services
        7.5.4 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Jubilant Life Sciences Recent Developments/Updates
        7.5.6 Jubilant Life Sciences Competitive Strengths & Weaknesses
    7.6 Bracco
        7.6.1 Bracco Details
        7.6.2 Bracco Major Business
        7.6.3 Bracco SPECT and PET Radiopharmaceuticals Product and Services
        7.6.4 Bracco SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Bracco Recent Developments/Updates
        7.6.6 Bracco Competitive Strengths & Weaknesses
    7.7 Yantai Dongcheng Pharmaceutical
        7.7.1 Yantai Dongcheng Pharmaceutical Details
        7.7.2 Yantai Dongcheng Pharmaceutical Major Business
        7.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product and Services
        7.7.4 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
        7.7.6 Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
    7.8 Lantheus Medical Imaging, Inc.
        7.8.1 Lantheus Medical Imaging, Inc. Details
        7.8.2 Lantheus Medical Imaging, Inc. Major Business
        7.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product and Services
        7.8.4 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Lantheus Medical Imaging, Inc. Recent Developments/Updates
        7.8.6 Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
    7.9 Eczacıbaşı Monrol Nuclear Products
        7.9.1 Eczacıbaşı Monrol Nuclear Products Details
        7.9.2 Eczacıbaşı Monrol Nuclear Products Major Business
        7.9.3 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product and Services
        7.9.4 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Eczacıbaşı Monrol Nuclear Products Recent Developments/Updates
        7.9.6 Eczacıbaşı Monrol Nuclear Products Competitive Strengths & Weaknesses
    7.10 Novartis International AG
        7.10.1 Novartis International AG Details
        7.10.2 Novartis International AG Major Business
        7.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Product and Services
        7.10.4 Novartis International AG SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis International AG Recent Developments/Updates
        7.10.6 Novartis International AG Competitive Strengths & Weaknesses
    7.11 Siemens
        7.11.1 Siemens Details
        7.11.2 Siemens Major Business
        7.11.3 Siemens SPECT and PET Radiopharmaceuticals Product and Services
        7.11.4 Siemens SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Siemens Recent Developments/Updates
        7.11.6 Siemens Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 SPECT and PET Radiopharmaceuticals Industry Chain
    8.2 SPECT and PET Radiopharmaceuticals Upstream Analysis
    8.3 SPECT and PET Radiopharmaceuticals Midstream Analysis
    8.4 SPECT and PET Radiopharmaceuticals Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World SPECT and PET Radiopharmaceuticals Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World SPECT and PET Radiopharmaceuticals Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World SPECT and PET Radiopharmaceuticals Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World SPECT and PET Radiopharmaceuticals Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World SPECT and PET Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World SPECT and PET Radiopharmaceuticals Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World SPECT and PET Radiopharmaceuticals Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key SPECT and PET Radiopharmaceuticals Players in 2022
    Table 12. World SPECT and PET Radiopharmaceuticals Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global SPECT and PET Radiopharmaceuticals Company Evaluation Quadrant
    Table 14. Head Office of Key SPECT and PET Radiopharmaceuticals Player
    Table 15. SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
    Table 16. SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
    Table 17. SPECT and PET Radiopharmaceuticals Mergers & Acquisitions Activity
    Table 18. United States VS China SPECT and PET Radiopharmaceuticals Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China SPECT and PET Radiopharmaceuticals Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based SPECT and PET Radiopharmaceuticals Companies, Headquarters (States, Country)
    Table 21. United States Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies SPECT and PET Radiopharmaceuticals Revenue Market Share (2018-2023)
    Table 23. China Based SPECT and PET Radiopharmaceuticals Companies, Headquarters (Province, Country)
    Table 24. China Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies SPECT and PET Radiopharmaceuticals Revenue Market Share (2018-2023)
    Table 26. Rest of World Based SPECT and PET Radiopharmaceuticals Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies SPECT and PET Radiopharmaceuticals Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies SPECT and PET Radiopharmaceuticals Revenue Market Share (2018-2023)
    Table 29. World SPECT and PET Radiopharmaceuticals Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & (USD Million)
    Table 31. World SPECT and PET Radiopharmaceuticals Market Size by Type (2024-2029) & (USD Million)
    Table 32. World SPECT and PET Radiopharmaceuticals Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & (USD Million)
    Table 34. World SPECT and PET Radiopharmaceuticals Market Size by Application (2024-2029) & (USD Million)
    Table 35. GE Healthcare Basic Information, Area Served and Competitors
    Table 36. GE Healthcare Major Business
    Table 37. GE Healthcare SPECT and PET Radiopharmaceuticals Product and Services
    Table 38. GE Healthcare SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. GE Healthcare Recent Developments/Updates
    Table 40. GE Healthcare Competitive Strengths & Weaknesses
    Table 41. Cardinal Health Basic Information, Area Served and Competitors
    Table 42. Cardinal Health Major Business
    Table 43. Cardinal Health SPECT and PET Radiopharmaceuticals Product and Services
    Table 44. Cardinal Health SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Cardinal Health Recent Developments/Updates
    Table 46. Cardinal Health Competitive Strengths & Weaknesses
    Table 47. Curium Pharma Basic Information, Area Served and Competitors
    Table 48. Curium Pharma Major Business
    Table 49. Curium Pharma SPECT and PET Radiopharmaceuticals Product and Services
    Table 50. Curium Pharma SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Curium Pharma Recent Developments/Updates
    Table 52. Curium Pharma Competitive Strengths & Weaknesses
    Table 53. China Isotope & Radiation Basic Information, Area Served and Competitors
    Table 54. China Isotope & Radiation Major Business
    Table 55. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Services
    Table 56. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. China Isotope & Radiation Recent Developments/Updates
    Table 58. China Isotope & Radiation Competitive Strengths & Weaknesses
    Table 59. Jubilant Life Sciences Basic Information, Area Served and Competitors
    Table 60. Jubilant Life Sciences Major Business
    Table 61. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product and Services
    Table 62. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Jubilant Life Sciences Recent Developments/Updates
    Table 64. Jubilant Life Sciences Competitive Strengths & Weaknesses
    Table 65. Bracco Basic Information, Area Served and Competitors
    Table 66. Bracco Major Business
    Table 67. Bracco SPECT and PET Radiopharmaceuticals Product and Services
    Table 68. Bracco SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Bracco Recent Developments/Updates
    Table 70. Bracco Competitive Strengths & Weaknesses
    Table 71. Yantai Dongcheng Pharmaceutical Basic Information, Area Served and Competitors
    Table 72. Yantai Dongcheng Pharmaceutical Major Business
    Table 73. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product and Services
    Table 74. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
    Table 76. Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
    Table 77. Lantheus Medical Imaging, Inc. Basic Information, Area Served and Competitors
    Table 78. Lantheus Medical Imaging, Inc. Major Business
    Table 79. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product and Services
    Table 80. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Lantheus Medical Imaging, Inc. Recent Developments/Updates
    Table 82. Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
    Table 83. Eczacıbaşı Monrol Nuclear Products Basic Information, Area Served and Competitors
    Table 84. Eczacıbaşı Monrol Nuclear Products Major Business
    Table 85. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product and Services
    Table 86. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Eczacıbaşı Monrol Nuclear Products Recent Developments/Updates
    Table 88. Eczacıbaşı Monrol Nuclear Products Competitive Strengths & Weaknesses
    Table 89. Novartis International AG Basic Information, Area Served and Competitors
    Table 90. Novartis International AG Major Business
    Table 91. Novartis International AG SPECT and PET Radiopharmaceuticals Product and Services
    Table 92. Novartis International AG SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Novartis International AG Recent Developments/Updates
    Table 94. Siemens Basic Information, Area Served and Competitors
    Table 95. Siemens Major Business
    Table 96. Siemens SPECT and PET Radiopharmaceuticals Product and Services
    Table 97. Siemens SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of SPECT and PET Radiopharmaceuticals Upstream (Raw Materials)
    Table 99. SPECT and PET Radiopharmaceuticals Typical Customers
List of Figure
    Figure 1. SPECT and PET Radiopharmaceuticals Picture
    Figure 2. World SPECT and PET Radiopharmaceuticals Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World SPECT and PET Radiopharmaceuticals Total Market Size (2018-2029) & (USD Million)
    Figure 4. World SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company SPECT and PET Radiopharmaceuticals Revenue (2018-2029) & (USD Million)
    Figure 13. SPECT and PET Radiopharmaceuticals Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 16. World SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 18. China SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 23. India SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of SPECT and PET Radiopharmaceuticals by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for SPECT and PET Radiopharmaceuticals Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for SPECT and PET Radiopharmaceuticals Markets in 2022
    Figure 27. United States VS China: SPECT and PET Radiopharmaceuticals Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: SPECT and PET Radiopharmaceuticals Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World SPECT and PET Radiopharmaceuticals Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World SPECT and PET Radiopharmaceuticals Market Size Market Share by Type in 2022
    Figure 31. Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
    Figure 32. Positron Emission Tomography (PET) Radiopharmaceuticals
    Figure 33. World SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2029)
    Figure 34. World SPECT and PET Radiopharmaceuticals Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World SPECT and PET Radiopharmaceuticals Market Size Market Share by Application in 2022
    Figure 36. Hospitals
    Figure 37. Clinics
    Figure 38. Others
    Figure 39. SPECT and PET Radiopharmaceuticals Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GE Healthcare
Cardinal Health
Curium Pharma
China Isotope & Radiation
Jubilant Life Sciences
Bracco
Yantai Dongcheng Pharmaceutical
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens

Related Reports

Global SPECT and PET Radiopharmaceuticals Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global SPECT and PET Radiopharmaceuticals Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Jul 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global SPECT and PET Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global SPECT and PET Radiopharmaceuticals Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global SPECT and PET Radiopharmaceuticals Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global SPECT and PET Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global SPECT and PET Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global SPECT and PET Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

date 13 Sep 2024

date Pharma & Healthcare

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Global SPECT and PET Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global SPECT and PET Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Sep 2024

date Pharma & Healthcare

Product Tags

SPECT and PET Radiopharmaceuticals

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>